Following an increasing trend since 2017, endocrine-related disorders are frequent irAEs of ICI therapy, involving disruptions in pituitary, thyroid, and adrenal functions, as well as diabetes [ 74 , 75 , 76 ].
← all excerpts
Immune Checkpoint Inhibitors and Male Fertility: Should Fertility Preservation Options Be Considered before Treatment?
1
—
—